Dominic Tilden

BCom MPH
Director

Dominic Tilden is a health economist with over a decade of practical experience in the design, development and implementation of health economic evaluations that involve cost-minimisation, cost-effectiveness, cost-utility and cost-benefit analyses. Dominic has worked in a broad range of therapeutic areas, including: oncology, cardiovascular diseases, diabetes, schizophrenia, ADHD, infectious diseases, osteoarthritis, thrombosis, transplantation, diagnostics, and screening.

Dominic has been an integral member of teams developing reimbursement applications globally. He has developed and implemented creative and analytical strategies, managed multidisciplinary teams and prepared submission dossiers that communicate sound health technology assessment and health economic arguments to reimbursement authorities in Australia, England, Wales, Scotland and several European countries. Since 1999, Dominic has been involved in and responsible for more than 30 reimbursement submissions to the Pharmaceutical Benefits Advisory Committee (Australia); the National Institute for Health and Clinical Excellence (England and Wales); and the Scottish Medicines Consortium. Dominic’s health economic evaluations have also been used in reimbursement applications in Canada, Finland, France, Germany, Holland, Norway, Portugal, Sweden and more.

Dominic develops models using first and second order Monte Carlo simulation; discrete event simulation; decision-analytic, Markov and semi-Markov architecture; and probabilistic sensitivity analyses. Models are developed in DATA software (TreeAge) or by applying advanced Excel techniques, including Visual Basic, where necessary. Dominic is contracted by TreeAge as an instructor for their DATA software training courses.

Participation in multidisciplinary research teams, and formal qualifications in public health, has equipped Dominic with expertise in health technology assessment techniques, including critical appraisal of clinical trial and epidemiological research data, meta-analysis and clinical trial data extraction.

Dominic has contributed to a substantial body of literature published in peer reviewed journals and government reports as a lead and contributing author in the domains of health economic evaluation and health technologies assessments. Dominic has also developed many highly successful and awarded poster presentations for conferences in Australia, Europe and the USA.

Suzi Cottrell

BSc(Hons) PhD
Senior Partner, Health Outcomes

Dr Suzi Cottrell is highly experienced in using and applying health technology assessment and systematic review methodologies, including meta-analysis, conducting patient preference, utility valuation and health-related quality of life studies and performing qualitative/quantitative health care research. Suzi has been involved in major drug reimbursement applications in the UK, as well as several other European countries and in Australia. Her experience covers many therapeutic and disease areas including: mental health, anti-malarial chemoprophylaxis, coronary heart disease, HIV, childhood vaccines, type 2 diabetes, rheumatoid arthritis, psoriasis, asthma and various cancer chemotherapies. She also has experience in diagnostic technology assessment in the field of cardiology. Suzi has an extensive publication record.

In her previous role, Suzi worked as a senior consultant and manager in health economics and outcomes research in the UK. Suzi was formerly engaged in toxicology research and chemical/drug safety assessment. She graduated with an honours degree in biochemistry from the University of Surrey, where she also completed her PhD studies in xenobiotic metabolism. Suzi took up her role at THEMA in 2008.

Mia Mudge

BAppSci
Senior Partner, Health Outcomes

Throughout her career in health technology assessment, Mia has worked on a wide variety of projects for the pharmaceutical industry and regulatory bodies. She has been involved in several major reimbursement applications for clients in Australia and internationally. Mia has also been involved in evaluating applications on behalf of the Medical Services Advisory Committee. Mia's particular interest is in systematic review and direct and indirect meta-analyses.

Mia graduated in 2002 with a Bachelor of Applied Science (Exercise and Sports Science) from the University of Sydney. A career as a health outcomes analyst in a health economic and outcomes research consultancy firm followed. She is currently studying at the University of Newcastle towards admission to the degree of Master of Medical Science (Clinical Epidemiology and Pharmacoeconomics). Mia joined THEMA in 2007.

Dan Jackson

BEc

Senior Partner, Health Economics

At THEMA, Dan applies his considerable technical expertise and interest in decision analytic modelling, economic evaluation, individual patient level analysis, and reimbursement strategies to a wide range of projects in many therapy areas. Dan has over 10 years experience in conducting economic evaluations of new health technologies in a wide range of therapeutic areas, and has worked in health economic consulting companies in both Australia and the UK. He has experience in preparing reimbursement submissions for Australia, New Zealand, and the UK.

Dan graduated from the University of Sydney with a degree in economics, majoring in economics and econometrics. Dan joined THEMA Consulting in 2009.

Koji Makino

BCom MCom GradCertPharmEc

Senior Partner, Health Economics

Koji's main focus at THEMA is formulation of market access and pricing strategies, market feasibility studies, preparation and evaluation of reimbursement applications, pricing assessment, and forecasting. Over the past 10 years, Koji has gained a sound understanding of reimbursement and pricing systems in Australia and overseas through a diverse range of health economics projects both as a consultant and in the health economics team of a global pharmaceutical company.

Koji has also worked as an evaluator of funding applications for new medical procedures on behalf of the Medical Services Advisory Committee for the Commonwealth Department of Health and Ageing. He is currently a research associate at Showa University, Japan. After completing a Master's degree in economics, Koji obtained a Graduate Certificate in Pharmacoeconomics from Monash University in 2006. Koji has been with THEMA since 2010.

Maria (Mish) Farris

BSc, GradDipDD, GradCertPharmEc

Maria has worked on market access for products including systematic reviews, reimbursement applications, hospital formulary submissions, conducting local epidemiological research, generating publications and providing guidance to key areas of business on product access as well as leading access strategies for a pharmaceutical company for a number of years.

After graduating with a Bachelor of Science from UTS, Maria worked in a variety of clinical laboratories. She then moved into the pharmaceutical industry conducting early to late phase clinical research and managing clinical quality control and staff training. During this time Maria completed her Graduate Diploma in Drug Development at the University of NSW. Her experience covers therapeutic/disease areas including: diabetes, dyslipidemia, cardiology, rheumatology, osteoarthritis, oncology, infectious disease and HIV. Maria has been part of the THEMA team since 2009 and has since completed a Graduate Certificate in Pharmacoeconomics at Monash University.

Lucas Tocchini

BPharm
Analyst

Lucas Graduated from the University of Sydney with a Bachelor of Pharmacy in 2005. He worked as a hospital pharmacist in public and private hospitals from 2005 to 2007. Lucas then worked in community pharmacy where he undertook primary compounding training and to work as a compounding pharmacist. In 2009, Lucas became accredited to practice as a Consultant Pharmacist and to undertake Medication Management Reviews in community and residential care settings.

Lucas is currently completing a Graduate Diploma in Health Economics and Policy at Monash University. To pursue his interest in the field of health economics, Lucas began working as an analyst at THEMA in 2008.

Brittany Maguire

BMedSci
Analyst

After completing her HSC at Loreto Normanhurst in 2007, Brittany went on to complete her Bachelor of Medical Science at University of Sydney in 2010. Within her degree Brittany was exposed to an array of disciplines including Anatomy, Histology, Biochemistry, Immunology, and Pathology before deciding to major in both Neuroscience and Physiology.

Upon completion of the BMedSci, Brittany worked as a contractor for an international biotechnology company where she was exposed to multiple roles and activities including marketing and product management. Brittany began working as a health outcomes analyst at THEMA in 2011 to pursue a career in Health Economics and Outcomes Research. She hopes to undertake her Masters in Public Health at University of Sydney in 2012.